127 related articles for article (PubMed ID: 9674417)
1. D-penicillamine-induced pemphigus foliaceus with autoantibodies to desmoglein-1.
Brenner S; Ruocco V
J Am Acad Dermatol; 1998 Jul; 39(1):137-8. PubMed ID: 9674417
[No Abstract] [Full Text] [Related]
2. Decline of anti-desmoglein 1 IgG ELISA scores by withdrawal of D-penicillamine in drug-induced pemphigus foliaceus.
Nagao K; Tanikawa A; Yamamoto N; Amagai M
Clin Exp Dermatol; 2005 Jan; 30(1):43-5. PubMed ID: 15663502
[TBL] [Abstract][Full Text] [Related]
3. D-penicillamine-induced pemphigus foliaceus with autoantibodies to desmoglein-1 in a patient with mixed connective tissue disease.
Peñas PF; Buezo GF; Carvajal I; Daudén E; López A; Diaz LA
J Am Acad Dermatol; 1997 Jul; 37(1):121-3. PubMed ID: 9216536
[No Abstract] [Full Text] [Related]
4. Recognition of pemphigus antigens in drug-induced pemphigus vulgaris and pemphigus foliaceus.
Brenner S; Bialy-Golan A; Anhalt GJ
J Am Acad Dermatol; 1997 Jun; 36(6 Pt 1):919-23. PubMed ID: 9204055
[TBL] [Abstract][Full Text] [Related]
5. [D-penicillamine-induced pemphigus: changes in anti-32-2B immunostaining patterns].
Khashoggi M; Machet L; Perrinaud A; Brive D; Machet MC; Maruani A; Vaillant L
Ann Dermatol Venereol; 2013; 140(8-9):531-4. PubMed ID: 24034638
[TBL] [Abstract][Full Text] [Related]
6. Development of pemphigus vulgaris in a patient with pemphigus foliaceus: antidesmoglein antibody profile shift confirmed by enzyme-linked immunosorbent assay.
Ishii K; Amagai M; Ohata Y; Shimizu H; Hashimoto T; Ohya K; Nishikawa T
J Am Acad Dermatol; 2000 May; 42(5 Pt 2):859-61. PubMed ID: 10767686
[TBL] [Abstract][Full Text] [Related]
7. Pemphigus erythematosus: detection of anti-desmoglein-1 antibodies by ELISA.
Gomi H; Kawada A; Amagai M; Matsuo I
Dermatology; 1999; 199(2):188-9. PubMed ID: 10559598
[No Abstract] [Full Text] [Related]
8. Protection against pemphigus foliaceus by desmoglein 3 in neonates.
Wu H; Wang ZH; Yan A; Lyle S; Fakharzadeh S; Wahl JK; Wheelock MJ; Ishikawa H; Uitto J; Amagai M; Stanley JR
N Engl J Med; 2000 Jul; 343(1):31-5. PubMed ID: 10882766
[No Abstract] [Full Text] [Related]
9. Limitations in enzyme-linked immunosorbent assays for antibodies against desmogleins 1 and 3 in patients with pemphigus.
Bystryn JC; Akman A; Jiao D
Arch Dermatol; 2002 Sep; 138(9):1252-3. PubMed ID: 12224997
[No Abstract] [Full Text] [Related]
10. D-penicillamine-induced pemphigus successfully treated with combination therapy of mizoribine and prednisolone.
Sugita K; Hirokawa H; Izu K; Tokura Y
J Dermatolog Treat; 2004 Jul; 15(4):214-7. PubMed ID: 15764033
[TBL] [Abstract][Full Text] [Related]
11. An experience for ELISA for desmoglein 1, suggesting a possible diagnostic help to determine the initial therapy for pemphigus foliaceus.
Aoyama Y; Tsujimura Y; Funabashi M; Sato M; Kamiya H; Kitajima Y
Eur J Dermatol; 2000; 10(1):18-21. PubMed ID: 10694292
[TBL] [Abstract][Full Text] [Related]
12. Explanations for the clinical and microscopic localization of lesions in pemphigus foliaceus and vulgaris.
Mahoney MG; Wang Z; Rothenberger K; Koch PJ; Amagai M; Stanley JR
J Clin Invest; 1999 Feb; 103(4):461-8. PubMed ID: 10021453
[TBL] [Abstract][Full Text] [Related]
13. The plant lectin wheat germ agglutinin inhibits the binding of pemphigus foliaceus autoantibodies to desmoglein 1 in a majority of patients and prevents pathomechanisms of pemphigus foliaceus in vitro and in vivo.
Ortiz-Urda S; Elbe-Bürger A; Smolle J; Marquart Y; Chudnovsky Y; Ridky TW; Bernstein P; Wolff K; Rappersberger K
J Immunol; 2003 Dec; 171(11):6244-50. PubMed ID: 14634141
[TBL] [Abstract][Full Text] [Related]
14. Photo quiz. Drug-induced pemphigus foliaceus.
Elston DM
Cutis; 2000 Nov; 66(5):332, 375-6. PubMed ID: 11107515
[No Abstract] [Full Text] [Related]
15. Drug-induced pemphigus: autoantibodies directed against the pemphigus antigen complexes are present in penicillamine and captopril-induced pemphigus.
Korman NJ; Eyre RW; Zone J; Stanley JR
J Invest Dermatol; 1991 Feb; 96(2):273-6. PubMed ID: 1991988
[TBL] [Abstract][Full Text] [Related]
16. Successful treatment of recalcitrant penicillamine-induced pemphigus foliaceus by low-dose intravenous immunoglobulins.
Tóth GG; Jonkman MF
Br J Dermatol; 1999 Sep; 141(3):583-5. PubMed ID: 10583082
[No Abstract] [Full Text] [Related]
17. Antibodies against desmoglein 3 (pemphigus vulgaris antigen) are present in sera from patients with paraneoplastic pemphigus and cause acantholysis in vivo in neonatal mice.
Amagai M; Nishikawa T; Nousari HC; Anhalt GJ; Hashimoto T
J Clin Invest; 1998 Aug; 102(4):775-82. PubMed ID: 9710446
[TBL] [Abstract][Full Text] [Related]
18. Pemphigus--decoding the cellular language of cutaneous autoimmunity.
Edelson RL
N Engl J Med; 2000 Jul; 343(1):60-1. PubMed ID: 10882772
[No Abstract] [Full Text] [Related]
19. The clinical phenotype of pemphigus is defined by the anti-desmoglein autoantibody profile.
Amagai M; Tsunoda K; Zillikens D; Nagai T; Nishikawa T
J Am Acad Dermatol; 1999 Feb; 40(2 Pt 1):167-70. PubMed ID: 10025740
[TBL] [Abstract][Full Text] [Related]
20. The transition of pemphigus vulgaris into pemphigus foliaceus: a reflection of changing desmoglein 1 and 3 autoantibody levels in pemphigus vulgaris.
Harman KE; Gratian MJ; Shirlaw PJ; Bhogal BS; Challacombe SJ; Black MM
Br J Dermatol; 2002 Apr; 146(4):684-7. PubMed ID: 11966706
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
